99 related articles for article (PubMed ID: 8200380)
1. Screening for cervical cancer in Poland.
Wronkowski Z; Zieliński J; Rekosz M
Eur J Gynaecol Oncol; 1993; 14 Suppl():81-5. PubMed ID: 8200380
[TBL] [Abstract][Full Text] [Related]
2. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
3. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the National Population-Based Cervical Cancer Screening Programme in Poland--outcomes, problems and possible solutions 7 years after implementation.
Januszek-Michalecka L; Nowak-Markwitz E; Banach P; Spaczynski M
Ann Agric Environ Med; 2013; 20(4):859-64. PubMed ID: 24364469
[TBL] [Abstract][Full Text] [Related]
5. Effect of population screening for carcinoma of the uterine cervix in Finland.
Hakama M
Maturitas; 1985 May; 7(1):3-10. PubMed ID: 4021826
[TBL] [Abstract][Full Text] [Related]
6. Reporting rates for cervical screening in the Szczecin Region during the period 2007-2010.
Owoc A; Cveijć R; Koprowicz A; Sygit K; Fronczak A; Bojar I
Ann Agric Environ Med; 2012; 19(4):686-91. PubMed ID: 23311790
[TBL] [Abstract][Full Text] [Related]
7. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
8. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
9. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
[TBL] [Abstract][Full Text] [Related]
10. [Widely available cytological examinations and detectability of cervical dysplasia and carcinoma].
Rózewicki S; Słomińska E; Choromański F; Niedzielski A
Ginekol Pol; 1989; 60(7-9):410-4. PubMed ID: 2702200
[TBL] [Abstract][Full Text] [Related]
11. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in Germany.
Schenck U; von Karsa L
Eur J Cancer; 2000 Nov; 36(17):2221-6. PubMed ID: 11072208
[TBL] [Abstract][Full Text] [Related]
13. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.
Anttila A; Pukkala E; Söderman B; Kallio M; Nieminen P; Hakama M
Int J Cancer; 1999 Sep; 83(1):59-65. PubMed ID: 10449609
[TBL] [Abstract][Full Text] [Related]
14. Cost-effective analysis of mass screening for cervical cancer in Japan.
Matsunaga G; Tsuji I; Sato S; Fukao A; Hisamichi S; Yajima A
J Epidemiol; 1997 Sep; 7(3):135-41. PubMed ID: 9337511
[TBL] [Abstract][Full Text] [Related]
15. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
van Oortmarssen GJ; Habbema JD
Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
[TBL] [Abstract][Full Text] [Related]
16. [Summary of the screening program for cervical cancer prevention in Poland for the first six months of 2007].
Spaczyński M; Malkowska-Walczak B
Ginekol Pol; 2007 Oct; 78(10):821-2. PubMed ID: 18200977
[No Abstract] [Full Text] [Related]
17. Screening for cancer of the uterine cervix in Greenland.
Nielsen NH; Jensen H
APMIS; 1993 Apr; 101(4):290-4. PubMed ID: 8323738
[TBL] [Abstract][Full Text] [Related]
18. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
20. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
Nowakowski A; Wojciechowska U; Wieszczy P; Cybulski M; Kamiński MF; Didkowska J
Eur J Epidemiol; 2017 Jun; 32(6):529-532. PubMed ID: 28780640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
